Tolerance to SARS-CoV-2 mRNA Vaccination in a Patient With Challenge-Confirmed PEG 2000 Allergy.

Faihs, V; Bent, R; Darsow, U; Biedermann, T; Brockow, K

Faihs, V; Bent, R; Darsow, U; Biedermann, T; Brockow, K.

Afiliação

Faihs V; Department of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany.
Bent R; Department of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany.
Darsow U; Department of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany.
Biedermann T; Department of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany.
Brockow K; Department of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany.

J Investig Allergol Clin Immunol ; 33(2): 149-150, 2023 04 18.

Article em En | MEDLINE | ID: mdl-35638391

Assuntos

Anafilaxia; COVID-19; Hipersensibilidade; Humanos; SARS-CoV-2; COVID-19/prevenção & controle; Vacinação/efeitos adversos; RNA Mensageiro; Polietilenoglicóis

Palavras-chave

Anaphylaxis; Polyethylene glycol; SARS-CoV-2. COVID-19; mRNA vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Hipersensibilidade / Anafilaxia Limite: Humans Idioma: En Revista: J Investig Allergol Clin Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google